US sues to block drug merger
FT News Briefing
00:00
Regulatory Scrutiny on Pharmaceutical Merger and Industry Implications
This chapter explores the regulatory apprehensions surrounding the merger of two major pharmaceutical companies and its implications for market power in drug distribution. It also highlights the companies' steadfast commitment to the merger amidst scrutiny, revealing the clash between corporate interests and consumer protection.
Transcript
Play full episode
